Skip to content

Home
Countries and Contacts
Transparency
English
- English
- Čeština
- Deutsch
- Ελληνικά
- Español
- Suomi
- Français
- Hrvatski
- Hungarian
- Italiano
- Dutch
- Slovenčina
Globe

Home
Countries and Contacts
Transparency
English
- English
- Čeština
- Deutsch
- Ελληνικά
- Español
- Suomi
- Français
- Hrvatski
- Hungarian
- Italiano
- Dutch
- Slovenčina
Globe

Mask Group 11

Transparency

Austria

TOV 2024:

Methodology – Multilingual

Austria – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Austria – Transparency Report ToVs 2025

Belgium

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Bulgaria

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Croatia

TOV 2024:

Methodology – Multilingual

Croatia – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Croatia-Transparency Report ToVs 2025

Cyprus

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Czech Republic

TOV 2024:

Methodology – Multilingual

Czech Republic – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Czech Republic-Transparency Report ToVs 2025

Denmark

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Estonia

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Finland

TOV 2024:

Methodology – Multilingual

Finland – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Finland-Transparency Report ToVs 2025

France

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Germany

TOV 2023:

Methodology Note

Transfer of Values to HCPs

Transfer of Values to HCO

TOV 2024:

Methodology – Multilingual

Germany – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Germany-Transparency Report ToVs 2025

Greece

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Hungary

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Iceland

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Ireland

TOV 2024:

Methodology – Multilingual

Ireland – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Ireland Transparency Report ToVs 2025

Italy

TOV 2024:

Methodology – Multilingual

Italy – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Italy- Transparency Report ToVs 2025

Latvia

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Liechtenstein

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Lithuania

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Luxembourg

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Malta

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Netherlands

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Norway

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Poland

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Portugal

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Portugal-Transparency Report ToVs 2025

Romania

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Slovakia

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Slovenia

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Spain

TOV 2024:

Methodology – Multilingual

Spain – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Spain- Transparency Report ToVs 2025

Sweden

TOV 2024:

Methodology – Multilingual

TOV 2025:

Methodology – Multilingual

Switzerland

TOV 2024:

Methodology – Multilingual

Switzerland – Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

Switzerland-Transparency Report ToVs 2025

UK

TOV 2024:

Methodology – Multilingual

UK Transparency Report ToVs 2024

TOV 2025:

Methodology – Multilingual

UK -Transparency Report ToVs 2025

Privacy Policy
Terms of use
Cookie Policy
Countries and Contacts

NON-2024-00001-HR

You are now leaving Biocon Biologics E.U., a Biocon Biologics website. The website you are about to access is not owned or controlled by Biocon Biologics. Biocon Biologics assumes no responsibility for and makes no warranties or representation of any kind as to the accuracy, currency, or completeness any information contained in such third-party website, including any third-party social media or mobile application platform. Inclusion of any third-party link on this website does not imply an endorsement or recommendation by Biocon Biologics, and a link to this website from another website does not imply a relationship between Biocon Biologics and any third party. Your use of any such third-party site or platform is at your own risk and will be governed by such third party’s terms and policies (including its privacy policy). Biocon Biologics shall not be liable for any direct, indirect, consequential, incidental or punitive damages arising out of access to, use of, or inability to use such third-party website, or any errors or omissions in the content thereof.

You are now departing from the Biocon Biologics EU website and redirected to the Biocon Biologics corporate website. Please be aware that the Biocon Biologics corporate website may contain information that varies from the content on the Biocon Biologics EU website. The website you are about to access is the corporate website located outside of Europe. European Union regulations may not be applicable to the content on this corporate website.